drugset / Trial / NCT00940160
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of QAX576 in Asthma Patients
RandomizedParallel-groupTriple-blindTreatment
Summary
This study is designed to investigate the safety and tolerability of multiple doses of QAX576 in controlled or partially controlled asthma patients.
Timeline
- Start
- 2009-07
- Primary completion
- 2010-01
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | QAX576 | Monoclonal antibody | 1 mg/kg | Intravenous |
| Comparator | QAX576 | Monoclonal antibody | 3 mg/kg | Intravenous |
| Comparator | QAX576 | Monoclonal antibody | 10 mg/kg | Intravenous |